273 related articles for article (PubMed ID: 31678141)
1. Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions.
Gala UH; Miller DA; Williams RO
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188319. PubMed ID: 31678141
[TBL] [Abstract][Full Text] [Related]
2. Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer.
Budiman A; Handini AL; Muslimah MN; Nurani NV; Laelasari E; Kurniawansyah IS; Aulifa DL
Polymers (Basel); 2023 Aug; 15(16):. PubMed ID: 37631436
[TBL] [Abstract][Full Text] [Related]
3. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update.
Jermain SV; Brough C; Williams RO
Int J Pharm; 2018 Jan; 535(1-2):379-392. PubMed ID: 29128423
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of increased bioavailability through amorphous solid dispersions: a review.
Schittny A; Huwyler J; Puchkov M
Drug Deliv; 2020 Dec; 27(1):110-127. PubMed ID: 31885288
[TBL] [Abstract][Full Text] [Related]
5. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.
Merisko-Liversidge E; Liversidge GG
Adv Drug Deliv Rev; 2011 May; 63(6):427-40. PubMed ID: 21223990
[TBL] [Abstract][Full Text] [Related]
6. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
Karwal R; Garg T; Rath G; Markandeywar TS
Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
[TBL] [Abstract][Full Text] [Related]
7. Ternary Solid Dispersions: A Review of the Preparation, Characterization, Mechanism of Drug Release, and Physical Stability.
Budiman A; Lailasari E; Nurani NV; Yunita EN; Anastasya G; Aulia RN; Lestari IN; Subra L; Aulifa DL
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631330
[TBL] [Abstract][Full Text] [Related]
8. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery.
Brough C; Williams RO
Int J Pharm; 2013 Aug; 453(1):157-66. PubMed ID: 23751341
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs.
Kumar S; Gupta SK
Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):111-21. PubMed ID: 23331062
[TBL] [Abstract][Full Text] [Related]
10. Amorphous drug delivery systems: molecular aspects, design, and performance.
Kaushal AM; Gupta P; Bansal AK
Crit Rev Ther Drug Carrier Syst; 2004; 21(3):133-93. PubMed ID: 15248808
[TBL] [Abstract][Full Text] [Related]
11. Amorphous Solid Dispersions: Utilization and Challenges in Drug Discovery and Development.
He Y; Ho C
J Pharm Sci; 2015 Oct; 104(10):3237-58. PubMed ID: 26175316
[TBL] [Abstract][Full Text] [Related]
12. Overview of the Manufacturing Methods of Solid Dispersion Technology for Improving the Solubility of Poorly Water-Soluble Drugs and Application to Anticancer Drugs.
Tran P; Pyo YC; Kim DH; Lee SE; Kim JK; Park JS
Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30893899
[TBL] [Abstract][Full Text] [Related]
13. Solid dispersions: revival with greater possibilities and applications in oral drug delivery.
Sethia S; Squillante E
Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):215-47. PubMed ID: 14584524
[TBL] [Abstract][Full Text] [Related]
14. Inventory of oral anticancer agents: Pharmaceutical formulation aspects with focus on the solid dispersion technique.
Sawicki E; Schellens JH; Beijnen JH; Nuijen B
Cancer Treat Rev; 2016 Nov; 50():247-263. PubMed ID: 27776286
[TBL] [Abstract][Full Text] [Related]
15. Solid Phospholipid Dispersions for Oral Delivery of Poorly Soluble Drugs: Investigation Into Celecoxib Incorporation and Solubility-In Vitro Permeability Enhancement.
Fong SY; Martins SM; Brandl M; Bauer-Brandl A
J Pharm Sci; 2016 Mar; 105(3):1113-23. PubMed ID: 26886329
[TBL] [Abstract][Full Text] [Related]
16. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
[TBL] [Abstract][Full Text] [Related]
17. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
Vo CL; Park C; Lee BJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
[TBL] [Abstract][Full Text] [Related]
18. Amorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption.
Rumondor ACF; Dhareshwar SS; Kesisoglou F
J Pharm Sci; 2016 Sep; 105(9):2498-2508. PubMed ID: 26886316
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Solid Dispersion Technology for Efficient Delivery of Poorly Water-Soluble Drugs.
Paudwal G; Rawat N; Gupta R; Baldi A; Singh G; Gupta PN
Curr Pharm Des; 2019; 25(13):1524-1535. PubMed ID: 31258070
[TBL] [Abstract][Full Text] [Related]
20. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.
Paudel A; Worku ZA; Meeus J; Guns S; Van den Mooter G
Int J Pharm; 2013 Aug; 453(1):253-84. PubMed ID: 22820134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
